Definitive Contract 75N91021C00009
Award Date
6/1/21
Potential Completion Date
5/31/28
Potential Value
$99M
Federal Agency
National Cancer Institute
Awardee
The Emmes Company LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $87,762,620.22 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) to The Emmes Company LLC, a for-profit limited liability company based in Rockville, Maryland. The contract is for providing direct organizational and data management support for specific clinical trials programs, as well as support for the NCI's Clinical Trials Evaluation Program (CTEP) staff in acquiring, reviewing, and analyzing data and information resulting from extramural clinical research....
This is a $27,798,450.48 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The Emmes Company LLC for clinical trials and information management support. The contract has no set-aside designation. The Emmes Company LLC is a global clinical research organization that provides a wide range of services to federal agencies, primarily NIH and its various institutes. Through this contract, Emmes will...
This is a $50,913,650.00 cost-plus-fixed-fee definitive contract awarded to The Emmes Company LLC by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to provide logistical and information technology support services for NCI's Central Institutional Review Board (CIRB). The contract has an ultimate completion date of August 31, 2029. The contract was awarded under a non-set-aside solicitation that sought proposals for operations management, customer...
The Emmes Company LLC was awarded a $4,683,571 cost plus fixed fee delivery order by the National Institutes of Health National Institute on Drug Abuse to serve as the Clinical Trials Network Clinical Coordinating Center from July 6, 2022 through July 5, 2023. As the prime contractor, The Emmes Company LLC will coordinate clinical trials and provide related support services for the Department of Health and Human Services agency's Clinical Trials Network program over the one-year period of...
This is a $799,919.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company. The contract supports the NIDA Data, Statistics, and Clinical Trial Support Center and covers a period from September 15, 2023 to March 31, 2025, with a final completion date of April 28, 2025. The contract is not set-aside. Emmes, a global clinical research organization, will provide...
This is a federal contract award from the National Cancer Institute (NCI) to The Emmes Company LLC, a global clinical research organization. The contract, valued at $49,737,331.00, is for logistical and IT support services for the NCI Central Institutional Review Board (CIRB). The contract is a definitive contract with a cost-plus-fixed-fee pricing type and has an ultimate completion date of August 31, 2024. The contract was awarded on September 1, 2019, and is not set aside for any specific...
This is a $36,506,288.06 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) to Theradex Systems, Inc. for clinical trials monitoring services. The contract has a performance period from May 1, 2017 to April 30, 2022. The contract supports NCI's Experimental Therapeutics Clinical Trials Network (ETCTN), National Clinical Trials Network (NCTN), and National Community Oncology Research Program (NCORP), as well as the NCI COVID-19 in Cancer Patients Study (NCCAPS) and the...
This is a $2,026,076.00 cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to The Emmes Company LLC. The contract is to provide biomedical and behavioral research resources and clinical research coordinating services to support NIDA's Clinical Trials Network (CTN) Helping to End Addiction Long-term (HEAL) studies. The period of performance is from February 26, 2024 to...
This is a $9,236,720 cost-plus-fixed-fee contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to The Emmes Company LLC, a global clinical research organization. The contract, titled "NINDS CENTER FOR CLINICAL TRIAL RESOURCES", has a period of performance through September 2027 and supports NINDS' clinical research program. The work includes quality assurance/control monitoring, statistical analysis, data management, and development of common data...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to The Emmes Company LLC, a for-profit limited liability company, to provide clinical coordinating center support services. The contract has a ceiling value of $3,744,211.88 and a period of performance from August 14, 2020 to August 13, 2021. The contract is not set aside for any specific business type. The Emmes Company LLC is a global clinical research organization...